Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence (Q33743024)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

8 references

24 March 2019

22 April 2019

25 June 2019

9 October 2019

20 November 2019

27 November 2019

13 December 2019

31 January 2021

Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence (English)

1 reference

Europe PubMed Central

29 July 2017

chronic obstructive pulmonary disease

8 references

24 March 2019

22 April 2019

25 June 2019

9 October 2019

20 November 2019

27 November 2019

13 December 2019

31 January 2021

alpha-1-antitrypsin deficiency

8 references

24 March 2019

22 April 2019

25 June 2019

9 October 2019

20 November 2019

27 November 2019

13 December 2019

31 January 2021

respiratory system

1 reference

9 October 2019

1 reference

20 November 2019

1 reference

27 November 2019

1 reference

13 December 2019

Serpin family A member 1

1 reference

31 January 2021

Marc Miravitlles

2

object named as

Marc Miravitlles

1 reference

Europe PubMed Central

29 July 2017

author name string

Franck F Rahaghi

1

1 reference

Europe PubMed Central

29 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 May 2017

9 references

Europe PubMed Central

29 July 2017

24 March 2019

22 April 2019

25 June 2019

9 October 2019

20 November 2019

27 November 2019

13 December 2019

31 January 2021

Respiratory Research

9 references

Europe PubMed Central

29 July 2017

24 March 2019

22 April 2019

25 June 2019

9 October 2019

20 November 2019

27 November 2019

13 December 2019

31 January 2021

18

1 reference

Europe PubMed Central

29 July 2017

105

1 reference

Europe PubMed Central

29 July 2017

1

1 reference

Europe PubMed Central

29 July 2017

copyright license

Creative Commons Attribution 4.0 International

8 references

Europe PubMed Central

24 March 2019

Europe PubMed Central

22 April 2019

Europe PubMed Central

25 June 2019

Europe PubMed Central

9 October 2019

Europe PubMed Central

20 November 2019

Europe PubMed Central

27 November 2019

Europe PubMed Central

13 December 2019

Europe PubMed Central

31 January 2021

copyright status

0 references

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1186/s12931-017-0574-1

0 references

Disease Modification in Emphysema Related to Alpha-1 Antitrypsin Deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Lung density associates with survival in alpha 1 antitrypsin deficient patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Disorders of protein misfolding: alpha-1-antitrypsin deficiency as prototype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Alpha-1 antitrypsin augmentation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

A review of α1-antitrypsin deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

The discovery of α1-antitrypsin and its role in health and disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Therapeutic efficacy of α-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

New Findings in PiZZ alpha1-antitrypsin deficiency-related panniculitis. Demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Liver disease in alpha 1-antitrypsin deficiency: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Chronic obstructive pulmonary disease: linking outcomes and pathobiology of disease modification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Delay in diagnosis of alpha1-antitrypsin deficiency: a continuing problem

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Predictors of mortality in alpha1-antitrypsin deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

21 June 2018

Detection of alpha-1 antitrypsin deficiency in the US.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

Changes in forced expiratory volume in 1 second over time in COPD.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

Progression parameters for emphysema: a clinical investigation.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

Usefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

Health-related quality of life in patients with alpha-1 antitrypsin deficiency: the French experience.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

Exacerbations in {alpha}1-antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report--2013; focus theme: age.

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

30 October 2018

[Prospective evaluation of clinical parameters of AAT patients with i. v. prolastin therapy in a homecare setting].

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

30 October 2018

Development of the new lung allocation system in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

30 October 2018

Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5450185

30 October 2018

Diagnóstico y tratamiento del déficit de alfa-1-antitripsina

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0574-1

21 January 2018

Airways obstruction and two year survival in patients with severe alpha 1-antitrypsin deficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/28558837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/28558837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute Registry of alpha 1-antitrypsin deficiency. Alpha 1-Antitrypsin Deficiency Registry Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/28558837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/28558837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline

1 reference

https://pubmed.ncbi.nlm.nih.gov/28558837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival benefit of lung transplantation in individuals with severe α1-anti-trypsin deficiency (PiZZ) and emphysema

1 reference

https://pubmed.ncbi.nlm.nih.gov/28558837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28558837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Guidelines for the diagnosis and management of alpha-1 antitrypsin deficiency]

1 reference

https://pubmed.ncbi.nlm.nih.gov/28558837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strong link between the alpha 1-antitrypsin PiZ allele and Wegener's granulomatosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28558837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of lung disease in a "normal" smoking population: are emphysema and airflow obstruction found together?

1 reference

https://pubmed.ncbi.nlm.nih.gov/28558837

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12931-017-0574-1

1 reference

Europe PubMed Central

29 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/s12931-017-0574-1

9 September 2019

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33743024&oldid=1621730454"